These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34510999)

  • 1. Workplace Support for Employees in Recovery From Opioid Use: Stakeholder Perspectives.
    Imboden R; Frey JJ; Bazell AT; Mosby A; Ware OD; Mitchell CS; Cloeren M
    New Solut; 2021 Nov; 31(3):340-349. PubMed ID: 34510999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. It Is Time to Implement Primary Prevention in the Workplace to Ameliorate the Ongoing U.S. Opioid Epidemic.
    Le AB; Rosen JD
    New Solut; 2021 Nov; 31(3):210-218. PubMed ID: 34431383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIOSH Responds to the U.S. Drug Overdose Epidemic.
    Osborne JC; Chosewood LC
    New Solut; 2021 Nov; 31(3):307-314. PubMed ID: 34431384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the Special Issue: Opioids and the Workplace - Risk Factors and Solutions.
    Rosen J; Zelnick JR; Zoeckler J; Landsbergis P
    New Solut; 2021 Nov; 31(3):201-209. PubMed ID: 34554026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Workplace Policies and Practices Regarding Employee Opioid Use.
    Cooper R; Bixler EA
    New Solut; 2021 Nov; 31(3):219-228. PubMed ID: 34353131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory study of barriers to inclusion in the European workplace.
    Moody L; Saunders J; Leber M; Wójcik-Augustyniak M; Szajczyk M; Rebernik N
    Disabil Rehabil; 2017 Oct; 39(20):2047-2054. PubMed ID: 27665671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and outcomes of paid undergraduate student nurse positions.
    Gamroth L; Budgen C; Lougheed M
    Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employing telehealth strategies for opioid addiction during COVID-19: implications for social work health care.
    Kim SH; Tesmer O
    Soc Work Health Care; 2021 Aug; 60(6-7):499-508. PubMed ID: 34278979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confronting Two Crises: The COVID-19 Pandemic, the Opioid Epidemic, and the Industrial Hygienist.
    Rosen J; Harnett P
    New Solut; 2021 Nov; 31(3):384-389. PubMed ID: 34233539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upsurges in the joblessness and opioid epidemics in the United States after the COVID-19 epidemic: the plight of the jobless patient in the clinic.
    Volinn E; Loeser JD
    Pain; 2021 Jun; 162(6):1608-1611. PubMed ID: 33657577
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid Addiction and Implications for Employers.
    Kuhn S
    Benefits Q; 2017; 33(1):33-36. PubMed ID: 29465184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tales from the frontlines: An alarming rise in hospitalizations related to opioid use disorder in the era of COVID-19.
    Ivey N; Clifton DC
    J Opioid Manag; 2021; 17(1):5-7. PubMed ID: 33735422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
    Henderson R; McInnes A; Mackey L; Bruised Head M; Crowshoe L; Hann J; Hayward J; Holroyd BR; Lang E; Larson B; Leonard AJ; Persaud S; Raghavji K; Sarin C; Virani H; Wadsworth IW; Whitman S; McLane P
    BMC Public Health; 2021 Jul; 21(1):1471. PubMed ID: 34320954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Big C"-stigma, cancer, and workplace discrimination.
    Stergiou-Kita M; Pritlove C; Kirsh B
    J Cancer Surviv; 2016 Dec; 10(6):1035-1050. PubMed ID: 27170116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
    Niles JK; Gudin J; Radcliff J; Kaufman HW
    Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-edged sword of using opioids and COVID-19: a toxicological view.
    Ataei M; Shirazi FM; Lamarine RJ; Nakhaee S; Mehrpour O
    Subst Abuse Treat Prev Policy; 2020 Dec; 15(1):91. PubMed ID: 33272308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons.
    Bandara S; Kennedy-Hendricks A; Merritt S; Barry CL; Saloner B
    J Addict Med; 2020; 14(5):e257-e260. PubMed ID: 32868681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.